Replies to post #8943 on Plandai Biotechnology Inc (PLPL)

[1 million]

So, what now of the stock price w/ a short squeeze,short term and long,$$$

[MrBiff]

WRONG. Not good news.
This is an "equity line" and it is not good news if you are a shareholder. Red flags abound.

There is no 8k filed so we don't know the details but there is lots of info out there on Lincoln Park Captial. They've been involved in dozens of these deals. What do they all have in common?
- companies being funded are tiny otc listed or troubled biotechs
- large funding commitment (over $10 million) but only a tiny amount upgfront
- Lincoln buys the stock at a discount to the current share price in small increments. Then they flip it for a quick profit. Shares can be sold immediately.

These are no-risk deals for Lincoln. Far from an endorsement, these deals show that Plandai is unable to attract legitimate investors.

And here's the really bad news. That tiny float that makes it possible for PLPL to go from 40c to 3 in days is gone. Each time Lincoln is forced to make a purchase, more shares will hit the market.